Civic AI
Procurement intelligence
Federal contract award
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE HLA TYPING AND ANTIBODY SCREENING REAGENTS TO THE HLA LAB FOR CLINICAL TESTING.
ONE LAMBDA, INC. · Department of Health and Human Services
- Value
- $81,694
- Start
- Apr 6, 2026
- End
- Apr 5, 2027
- Action date
- Apr 1, 2026
- PIID
- 75N98026P00205
- Status
- active
- NAICS
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- Place of performance
- CANOGA PARK, CA
- Award type
- PURCHASE ORDER
Description
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE HLA TYPING AND ANTIBODY SCREENING REAGENTS TO THE HLA LAB FOR CLINICAL TESTING.
Need modifications, related awards, and vendor peers? Open the full award workspace.